Table 2.
Cox regression models for the relationship between DM and mortality in MAFLD patients.
| Model 1 | Model 2 | Model 3 | |||||
|---|---|---|---|---|---|---|---|
| Unadjusted HR | HR (95% Cl) | p-Value | HR (95% Cl) | p-Value | HR (95% Cl) | p-Value | |
| All-cause mortality | 1.459 (1.310, 1.623) |
1.546 (1.381, 1.732) |
<0.001 | 1.564 (1.395, 1.753) |
<0.001 | 1.428 (1.257, 1.623) |
<0.001 |
| Cardiovascular mortality | 1.482 (1.183, 1.858) |
1.546 (1.221, 2.230) |
<0.001 | 1.526 (1.204, 1.935) |
<0.001 | 1.464 (1.122, 1.909) |
0.005 |
| Cancer mortality | 0.993 (0.791, 1.246) |
1.143 (0.903, 1.447) |
0.267 | 1.173 (0.924, 1.489) |
0.189 | 1.026 (0.787, 1.336) |
0.851 |
| Non-cardiovascular-related mortality | 1.448 (1.282, 1.637) |
1.546 (1.358, 1.760) |
<0.001 | 1.575 (1.382, 1.796) |
<0.001 | 1.423 (1.229, 1.647) |
<0.001 |
| Non-cancer-related mortality | 1.627 (1.439, 1.840) |
1.696 (1.489, 1.932) |
<0.001 | 1.709 (1.499, 1.948) |
<0.001 | 1.587 (1.370, 1.838) |
<0.001 |
The results were obtained with Cox proportional hazards analysis and are given as HR with 95% Cl. Model 1: adjusted by age, gender, ethnicity, and poverty income ratio (PIR). Model 2: model 1 + adjusted by hypertension and BMI. Model 3: model 2 + adjusted by vitamin C, ALP, ALB, SCR, and NFS scores.